Not Tagged
Not Tagged
['melanoma']
update on tumor-infiltrating lymphocytes emerging as the preferred option for pd1 refractory #melanoma by &amp; so many other trials in this space &amp; cellular therapy #asco22 - considerations for pt selection, tumor banking, bridging therapy &amp; $$ 
GU Oncology Fellow | NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | #ASCO22 Featured Voice | COI: https://t.co/X1Y9QuHs6L